Published on 23 Apr 2024 on GuruFocus.com via Yahoo Finance
Medpace Holdings Inc (MEDP) Surpasses Analyst Revenue and Earnings Projections in Q1 2024
Revenue: Reported at $511.0 million for Q1 2024, up 17.7% year-over-year, slightly below the estimate of $512.59 million.Net Income: Achieved $102.6 million in Q1 2024, significantly exceeding the estimated $78.67 million, with a net income margin improvement to 20.1% from 16.8% year-over-year.Earnings Per Share (EPS): Recorded at $3.20 per diluted share, surpassing the estimated $2.47.EBITDA: Increased by 24.6% to $115.7 million in Q1 2024, with an EBITDA margin of 22.6%, reflecting operational efficiency improvements.Net Book-to-Bill Ratio: Stood at 1.20x due to net new business awards of $615.6 million, indicating robust future revenue potential.Cash Flow: Generated $152.7 million from operating activities, supporting strong liquidity and financial health.2024 Financial Guidance: Projects revenue between $2.150 billion and $2.200 billion and GAAP net income between $347.0 million and $369.0 million, with EPS ranging from $10.79 to $11.47.
Warning! GuruFocus has detected 5 Warning Sign with MEDP.